KREN

Kenneth Griffin Portfolio

Kenneth Griffin · Citadel Advisors — SEC 13F/HR filings · Report date 2025-06-30

$575.96B13F reported value (previous quarter $575.96B)
200Equity holdings
10.5%Displayed equity weight (remaining: options/other)
NVDA 0.2%, HESM 0.2%, AMZN 0.2%Top 3 holdings weight

About this page

Large institutional investment managers report qualifying US holdings quarterly through 13F filings with the SEC. We parse the original XML to display portfolio weights and quarterly position changes. Current prices and returns are indicative estimates.

Security ▲▼ Portfolio weight ▲▼ Shares held ▲▼ Reported value ▲▼ Current price ▲▼ Estimated cost basis ▲▼ Estimated return ▲▼ Latest quarter activity
NVDANVIDIACommon stock 0.22% 8,086,761 $1.28B $216.52 $115.06 +88.2% Added (2025Q2) +6,513,348 shares
Holding history

Quarterly holding historyCOM

QuarterSharesShare ΔValueSEC
2024 Q3118,712,400—$14.42B—
2024 Q4127,041,296+8,328,896$17.06B—
2025 Q187,047,200-39,994,096$9.43B—
2025 Q281,972,096-5,075,104$12.95B—
2025 Q377,694,400-4,277,696$14.50B—
2025 Q477,938,304+243,904$14.54B—
2026 Q166,888,000-11,050,304$11.67B—
2026 Q260,899,600-5,988,400$12.19B—
HESMHess Midstream LPCommon stock 0.21% 8,915,548 $1.24B $30.66 $35.98 -14.8% Added (2025Q2) +546,925 shares
AMZNAmazonCommon stock 0.20% 5,336,333 $1.17B $262.43 $184.87 +42.0% Added (2025Q2) +3,265,174 shares
Holding history

Quarterly holding historyCOM

QuarterSharesShare ΔValueSEC
2024 Q316,968,000—$3.16B—
2024 Q418,210,900+1,242,900$4.00B—
2025 Q119,649,900+1,439,000$3.74B—
2025 Q218,137,500-1,512,400$3.98B—
2025 Q324,971,600+6,834,100$5.48B—
2025 Q423,200,200-1,771,400$5.36B—
2026 Q125,370,500+2,170,300$5.28B—
2026 Q224,885,700-484,800$5.93B—
EWEdwards Lifesciences CorporationCommon stock 0.17% 12,731,291 $1.00B $86.60 $67.20 +28.9% Reduced (2025Q2) -650,392 shares
AMJBAlerian MLP Index ETNCommon stock 0.17% 3,403,405 $0.99B $34.87 $28.44 +22.6% Added (2025Q2) +1,148,586 shares
Holding history

Quarterly holding historyCOM

QuarterSharesShare ΔValueSEC
2026 Q15,695,700—$1.68B—
2026 Q25,809,800+114,100$1.90B—
MSFTMicrosoft CorporationCommon stock 0.17% 1,980,739 $0.99B $535.07 $424.23 +26.1% Added (2025Q2) +1,866,625 shares
Holding history

Quarterly holding historyCOM

QuarterSharesShare ΔValueSEC
2024 Q313,974,800—$6.01B—
2024 Q415,874,500+1,899,700$6.69B—
2025 Q111,240,300-4,634,200$4.22B—
2025 Q210,800,600-439,700$5.37B—
2025 Q313,413,400+2,612,800$6.95B—
2025 Q412,509,200-904,200$6.05B—
2026 Q118,974,800+6,465,600$7.02B—
2026 Q225,992,400+7,017,600$9.70B—
MDTMedtronic plcCommon stock 0.15% 9,796,855 $0.85B $94.75 $89.74 +5.6% Added (2025Q2) +1,135,688 shares
TXNTexas Instruments IncorporatedCommon stock 0.14% 3,784,102 $0.79B $283.74 $202.72 +40.0% Added (2025Q2) +3,089,922 shares
HDThe Home Depot, Inc.Common stock 0.14% 2,140,064 $0.78B $310.70 $381.65 -18.6% Added (2025Q2) +494,775 shares
MDLZMondelez International, Inc.A class shares 0.14% 11,617,484 $0.78B — $74.62 — Added (2025Q2) +5,950,798 shares
MCDMcDonald's CorporationCommon stock 0.14% 2,661,364 $0.78B $242.70 $294.88 -17.7% Added (2025Q2) +2,608,742 shares
COFCapital One Financial CorporationCommon stock 0.13% 3,553,889 $0.76B $197.74 $144.62 +36.7% Added (2025Q2) +954,296 shares
GEHCGE HealthCare Technologies Inc.Common stock 0.12% 9,299,929 $0.69B $70.16 $88.71 -20.9% Added (2025Q2) +2,383,389 shares
KOCoca-ColaCommon stock 0.12% 9,651,763 $0.68B $88.05 $71.62 +22.9% Added (2025Q2) +9,189,158 shares
LLYEli LillyCommon stock 0.12% 853,252 $0.67B $1,257.03 $915.96 +37.2% Added (2025Q2) +375,471 shares
Holding history

Quarterly holding historyCOM

QuarterSharesShare ΔValueSEC
2024 Q31,441,700—$1.28B—
2024 Q41,856,700+415,000$1.43B—
2025 Q11,649,500-207,200$1.36B—
2025 Q21,720,500+71,000$1.34B—
2025 Q32,229,400+508,900$1.70B—
2025 Q42,088,800-140,600$2.24B—
2026 Q11,581,800-507,000$1.45B—
2026 Q22,349,200+767,400$2.82B—
TAT&T Inc.Common stock 0.11% 21,962,428 $0.64B $23.44 $21.47 +9.2% Added (2025Q2) +6,843,152 shares
CSCOCisco SystemsCommon stock 0.11% 9,113,065 $0.63B $108.41 $50.77 +113.5% Added (2025Q2) +2,380,802 shares
LRCXLam Research CorporationCommon stock 0.11% 6,369,307 $0.62B $263.94 $77.41 +241.0% Reduced (2025Q2) -283,721 shares
GILDGilead SciencesCommon stock 0.11% 5,470,545 $0.61B $151.17 $82.11 +84.1% Held Unchanged
ABBVAbbVieCommon stock 0.10% 3,252,861 $0.60B $285.42 $194.58 +46.7% Added (2025Q2) +1,405,899 shares

Options positions (calls/puts)

Security Type Portfolio weight Underlying shares Reported value
AMDAdvanced Micro Devices Long call 0.59% 23,934,200 $3.40B
AMDAdvanced Micro Devices Long put 0.40% 16,219,500 $2.30B
BABAAlibaba Group Long call 0.24% 12,177,600 $1.38B
ADBEAdobe Long call 0.16% 2,372,000 $0.92B
BABAAlibaba Group Long put 0.13% 6,775,000 $0.77B
ADBEAdobe Long put 0.10% 1,557,500 $0.60B
ABBVAbbVie Long call 0.07% 2,253,900 $0.42B
ABTAbbott Laboratories Long call 0.05% 2,120,700 $0.29B
ABNBAirbnb Long call 0.04% 1,920,900 $0.25B
ABBVAbbVie Long put 0.04% 1,240,900 $0.23B
ACCENTURE PLC IRELAND Long call 0.04% 714,100 $0.21B
AFRMAffirm Holdings Long call 0.03% 2,895,800 $0.20B
ABNBAirbnb Long put 0.03% 1,307,700 $0.17B
AEMAgnico Eagle Mines Limited Long call 0.03% 1,426,800 $0.17B
MMM3M Company Long call 0.03% 960,500 $0.15B
ANFAbercrombie & Fitch Co. Long put 0.02% 1,576,900 $0.13B
ABTAbbott Laboratories Long put 0.02% 940,700 $0.13B
AFRMAffirm Holdings Long put 0.02% 1,688,000 $0.12B
ACCENTURE PLC IRELAND Long put 0.02% 360,500 $0.11B
ALBAlbemarle Long put 0.02% 1,697,100 $0.11B

13F option rows report underlying share counts and reported underlying value. They are excluded from the equity holdings table.

Quarterly 13F history

Click a quarter to switch the whole page to that quarter's snapshot.

QuarterFiledReported valueSEC filing
2026 Q22026-09-02$875.01B—
2026 Q12026-05-15$618.47B—
2025 Q42026-02-17$665.87B—
2025 Q32025-11-14$657.15B—
2025 Q2Viewing2025-08-14$575.96B—
2025 Q12025-05-15$527.32B—
2024 Q42025-02-14$577.87B—
2024 Q32024-11-14$518.30B—

New 1644 · Added 5347 · Trimmed 4871 · Exited 3723

* Estimated cost basis: 13F filings do not disclose average purchase prices. For new positions since 2024 Q9, we estimate the cost basis using quarterly average prices. Positions with partial sales are marked unavailable. Returns based on these estimates are for reference only.

This page mechanically processes original 13F/HR filings on SEC EDGAR. Holdings are reported as of quarter-end and filings are submitted within 45 days, so actual holdings may differ. Coverage of options, derivatives, foreign equities and warrants may be limited. Do not rely on this page alone for investment decisions; verify the original filings at SEC EDGAR.